 | Harvard Bioscience, Inc. | |||
| NGM : HBIO || Location: United States | ||||
$3.72+0.02 (+0.54%) |
0.09 M | 3.63 - 3.84 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.637 M |
| March 15, 2024 | 0.717 M |
| Feb. 29, 2024 | 0.713 M |
| Feb. 15, 2024 | 0.738 M |
| Jan. 31, 2024 | 0.789 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | 0.05 | 0.04 | -21.57% |
| 09/30/2023 | 0.04 | 0.01 | -75.49% |
| 06/30/2023 | 0.06 | 0.04 | -38.08% |
| 03/31/2023 | 0.05 | 0.06 | 17.65% |
| 12/31/2022 | 0.03 | 0.04 | 17.65% |
HBIO Basic Data
| Sector | Healthcare | Industry | Medical Instruments & Supplies |
| Shares Outstanding | 43.421M | Shares Float | 35.098M |
| Short Float | 0.637M | Market Cap | 160.66M |
| Institution ownership | 78.41% | Insider ownership | 7.285% |
| Earnings Date | 05/02/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -0.08 | Forward EPS | 0.29 |